Corrigendum: Induction of monocyte chemoattractant proteins in macrophages via the production of Granulocyte/Macrophage Colony-Stimulating Factor By Breast Cancer Cells [Front Immunol, 7, (2016) (2)] DOI:10.3389/fimmu.2016.00002;Induction of monocyte chemoattractant proteins in macrophages via the production of granulocyte/macrophage colony-stimulating factor by breast cancer cells

Frontiers in Immunology

Volumn 7, Issue JAN, 2016, Pages

  Yoshimura, Teizo ^a,b   Imamichi, Tomozumi ^c   Weiss, Jonathan M ^a   Sato, Miwa ^b   Li, Liangzhu ^d   Matsukawa, Akihiro ^b   Wang, Ji Ming ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b OKAYAMA UNIVERSITY   (Japan)

^c FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Breast cancer; Chemokines; Inflammation; Monocytes macrophages; Tumor microenvironment

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 5;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CELL ACTIVATION; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; LEUKOCYTE; LUNG METASTASIS; MACROPHAGE; MOUSE; NONHUMAN; NORTHERN BLOTTING; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; UPREGULATION;

EID: 84958166353     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.01524     Document Type: Erratum

References (48)

1. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature (2008) 454:436-44. doi: 10.1038/nature07205
2. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell (2010) 140:883-99. doi:10.1016/j.cell.2010.01.025
3. Yoshimura T, Robinson EA, Tanaka S, Appella E, Kuratsu J, Leonard EJ. Purification and amino acid analysis of two human glioma cell-derived monocyte chemoattractants. J Exp Med (1989) 169:1449-59. doi:10.1084/jem.169.4.1449
4. Matsushima K, Larsen CG, DuBois GC, Oppenheim JJ. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med (1989) 169:1485-90. doi:10.1084/jem.169.4.1485
5. Bottazzi B, Colotta F, Sica A, Nobili N, Mantovani A. A chemoattractant expressed in human sarcoma cells (tumor-derived chemotactic factor, TDCF) is identical to monocyte chemoattractant protein-1/monocyte chemotactic and activating factor (MCP-1/MCAF). Int J Cancer (1990) 45:795-7. doi:10.1002/ijc.2910450436
6. Moore RJ, Owens DM, Stamp G, Arnott C, Burke F, East N, et al. Mice deficient in tumor necrosis factor-a are resistant to skin carcinogenesis. Nat Med (1999) 5:828-31. doi:10.1038/10462
7. Popivanova BK, Kostadinova FI, Furuichi K, Shamekh MM, Kondo T, Wada T, et al. Blockade of a chemokine, CCL2, reduces chronic colitis-associated carcinogenesis in mice. Cancer Res (2009) 69:7884-92. doi:10.1158/0008-5472.CAN-09-1451
8. Loberg RD, Ying C, Craig M, Day LL, Sargent E, Neeley C, et al. Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo. Cancer Res (2007) 67:9417-24. doi:10.1158/0008-5472.CAN-07-1286
9. Lu Y, Cai Z, Xiao G, Keller ET, Mizokami A, Yao Z, et al. Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption. Cancer Res (2007) 67:3646-53. doi:10.1158/0008-5472.CAN-06-1210
10. Li X, Loberg R, Liao J, Ying C, Snyder LA, Pienta KJ, et al. A destructive cascade mediated by CCL2 facilitates prostate cancer growth in bone. Cancer Res (2009) 69:1685-92. doi:10.1158/0008-5472.CAN-08-2164
11. Lu X, Kang Y. Chemokine (C-C motif) ligand 2 engages CCR2+ stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone. J Biol Chem (2009) 284:29087-96. doi:10.1074/jbc. M109.035899
12. Qian BZ, Li J, Zhang H, Kitamura T, Zhang J, Campion LR, et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature (2011) 475:222-5. doi:10.1038/nature10138
13. Fridlender ZG, Kapoor V, Buchlis G, Cheng G, Sun J, Wang LC, et al. CCL2 blockade inhibits lung cancer tumor growth by altering macrophage phenotype and activating CD8+ cells. Am J Respir Cell Mol Biol (2011) 44:230-7. doi:10.1165/rcmb.2010-0080OC
14. Garber K. First results for agents targeting cancer-related inflammation. J Natl Cancer Inst (2010) 101:1110-2. doi:10.1093/jnci/djp266
15. Heppner GH, Miller FR, Shekhar PVM. Nontransgenic models of breast cancer. Breast Cancer Res (2000) 2:331-4. doi:10.1186/bcr77
16. Yoshimura T, Howard OMZ, Ito T, Kuwabara M, Matsukawa A, Chen K, et al. Monocyte chemoattractant protein-1/CCL2 produced by stromal cells promotes lung metastasis of 4T1 murine breast cancer cells. PLoS One (2013) 8:e58791. doi:10.1371/journal.pone.0058791
17. Takahashi M, Galligan C, Tessarollo L, Yoshimura T. Monocyte chemoattractant protein-1 (MCP-1), not MCP-3, is the primary chemokine required for monocyte recruitment in mouse peritonitis induced with thioglycollate or zymosan A. J Immunol (2009) 183:3463-71. doi:10.4049/jimmunol.0802812
18. Yoshimura T, Galligan C, Takahashi M, Chen K, Liu M, Tessarollo L, et al. Non-myeloid cells are major contributors to innate immune responses via production of monocyte chemoattractant protein-1/CCL2. Front Immunol (2014) 4:482. doi:10.3389/fimmu.2013.00482
19. Clausen BE, Burkhardt C, Reith W, Renkawitz R, Forster I. Conditional gene targeting in macrophage and granulocytes using LysMcre mice. Transgenic Res (1999) 8:265-77. doi:10.1023/A:1008942828960
20. Yoshimura T, Johnson DG. cDNA cloning and expression of guinea pig neutrophil attractant protein-1 (NAP-1): NAP-1 is highly conserved in guinea pig. J Immunol (1993) 151:6225-36.
21. Yoshimura T, Yuhki N, Moore SK, Appella E, Lerman MI, Leonard EJ. Human monocyte chemoattractant protein-1 (MCP-1): full length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett (1989) 244:487-93. doi:10.1016/0014-5793(89)80590-3
22. Yamashiro S, Kamohara H, Yoshimura T. MCP-1 is selectively expressed in the late phase by cytokine-stimulated human neutrophils: TNF-α plays a role in the maximal MCP-1 mRNA expression. J Leukoc Biol (1999) 65:671-9.
23. Geiss GK, Bumgarner RE, Birditt B, Dahl T, Dowidar N, Dunaway DL, et al. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol (2008) 26:317-25. doi:10.1038/nbt0608-709c
24. Burvall K, Palmberg L, Larsson K. Expression of TNFalpha and its receptors R1 and R2 in human alveolar epithelial cells exposed to organic dust and the effects of 8-bromo-cAMP and protein kinase A modulation. Inflamm Res (2005) 54:281-8. doi:10.1007/s00011-005-1356-7
25. Apte RN, Dotan S, Elkabets M, White MR, Reich E, Carmi Y, et al. The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev (2006) 25:387-408. doi:10.1007/s10555-006-9004-4
26. Kim S, Takahashi H, Lin WW, Descargues P, Grivennikov S, Kim Y, et al. Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature (2009) 457:102-6. doi:10.1038/nature07623
27. Irvine KM, Andrews MR, Fernandez-Rojo MA, Schroder K, Burns CJ, Su S, et al. Colony-stimulating factor-1 (CSF-1) delivers a proatherogenic signal to human macrophages. J Leukoc Biol (2009) 85:278-88. doi:10.1189/jlb.0808497
28. Sund M, Kalluri R. Tumor stroma derived biomarkers in cancer. Cancer Metastasis Rev (2009) 28:177-83. doi:10.1007/s10555-008-9175-2
29. Albini A, Sporn MB. The tumour microenvironment as a target for chemoprevention. Nature Rev (2007) 7:139-47. doi:10.1038/nrc2067
30. Weiseman BS, Werb Z. Stromal effects on mammary gland development and breast cancer. Science (2002) 296:1046-9. doi:10.1126/science.1067431
31. Tang R, Beuvon F, Ojeda M, Mosseri V, Pouillart P, Scholl S. M-CSF (monocyte colony stimulating factor) and M-CSF receptor expression by breast tumour cells: M-CSF mediated recruitment of tumour infiltrating monocytes? J Cell Biochem (1992) 50:350-6. doi:10.1002/jcb.240500403
32. Sapi E. The role of CSF-1 in normal physiology of mammary gland and breast cancer: an update. Exp Biol Med (2004) 229:1-11.
33. Scholl SM, Lidereau R, de la Rochefordière A, Le-Nir CC, Mosseri V, Noguès C, et al. Circulating levels of the macrophage colony stimulating factor CSF-1 in primary and metastatic breast cancer patients. A pilot study. Breast Cancer Res Treat (1996) 39:275-83. doi:10.1007/BF01806155
34. Kacinski BM. CSF-1 and its receptor in ovarian, endometrial and breast cancer. Ann Med (1995) 27:79-85. doi:10.3109/07853899509031941
35. Lin EY, Nguyen AV, Russell RG, Pollard JW. Colony-stimulating factor promotes progression of mammary tumors to malignancy. J Exp Med (2001) 193:727-39. doi:10.1084/jem.193.6.727
36. Eda H, Zhang J, Keith RH, Michener M, Beidler DR, Monahan JB. Macrophage-colony stimulating factor and interleukin-34 induce chemokines in human whole blood. Cytokine (2010) 52:215-20. doi:10.1016/j.cyto.2010.08.005
37. Monti F, Szymczuk S, Motta MR, Benini C, Fattori PP, Pini E, et al. GM-CSF production in human adenocarcinoma cell lines. J Biol Regul Homeost Agents (1993) 7:85-91.
38. Su S, Liu Q, Chen J, Chen J, Chen F, He C, et al. A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis. Cancer Cell (2014) 25:605-20. doi:10.1016/j.ccr.2014.03.021
39. Fujimoto H, Sangai T, Ishii G, Ikehara A, Nagashima T, Miyazaki M, et al. Stromal MCP-1 in mammary tumors induces tumo-associated macrophage infiltration and contributes to tumor progression. Int J Cancer (2009) 125:1276-84. doi:10.1002/ijc.24378
40. Burgess AW, Camakaris J, Metcalf D. Purification and properties of colony-stimulating factor from mouse lung-conditioned medium. J Biol Chem (1977) 252:1998-2003.
41. Murphy PM, Baggiolini M, Charo IF, Hebert CA, Horuk R, Matsushima K, et al. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev (2000) 52:145-76.
42. DranoffG. GM-CSF-based cancer vaccines. Immunol Rev (2002) 188:147-54. doi:10.1034/j.1600-065X.2002.18813.x
43. Rollins BJ. Chemokines. Blood (1997) 90:909-28.
44. Tsuyada A, Chow A, Wu J, Somlo G, Chu P, Loera S, et al. CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells. Cancer Res (2012) 72:2768-79. doi:10.1158/0008-5472.CAN-11-3567
45. Takeda K, Hatakeyama K, Tsuchiya Y, Rikiishi H, Kumagai K. A correlation between GM-CSF gene expression and metastases in murine tumors. Int J Cancer (1991) 47:413-20. doi:10.1002/ijc.2910470318
46. Hamilton JA. Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol (2008) 8:533-44. doi:10.1038/nri2356
47. Di Carto E, Forni G, Lollini P, Colombo MP, Modesti A, Musiani P. The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood (2001) 97:339-45. doi:10.1182/blood. V97.2.339
48. Yoshimura T, Liu M, Chen X, Li L, Wang J-M. Crosstalk between tumor cells and macrophages in stroma renders tumor cells as the primary source of MCP-1/CCL2 in Lewis lung carcinoma. Front Immunol (2015) 6:332. doi:10.3389/fimmu.2015.00332